Lootman wrote:It was a reference to the replies to what I think was your poll about face coverings. Since then Covid has mostly dropped out of the news.
And also much less posting about Covid here on TLF, although a handful here still see it as a risk.
Well there's only so much to say, and those who think one way will do their thing, and those who think differently will do their thing. But if you don't think it's still a risk, it looks like the BA.4/5 wave is starting, accelerated by the Jubilee superspreader event - see
my post on the numbers thread :
Hospital admissions with COVID are rising sharply across England, up 33% week-on-week. Admissions rose by between 23% and 50% in all English regions. Bed occupancy is up by 12%.
Hospital deaths with COVID are no longer falling. Our estimate suggests deaths rose by 8% this week....
the current rate of increase in hospital admissions is faster than we saw during the BA.2 Omicron wave in March.
This chart shows what that means as an R estimate, currently approaching 1.2.The
presentation from a professor of biosecurity may also be of interest to people here.
redsturgeon wrote:No private supply is being made available yet from the manufacturers, I do not know the reason.
I imagine that's a conscious choice by the vaccine makers to deal with governments and the WHO for the time being. It makes sense just in terms of basic equity to do it that way until everyone on the planet has had their first and second jabs, but also they're not making enough on a per-jab basis to justify the bad headlines from the rich "buying their way to the front of the queue" - there was a real outcry in the early days of the jab when the rich in somewhere like Qatar were buying jabs for $20k or something daft. The manufacturers have a huge backlog, they don't need the hassle of private sales.
As for UK plans, although
the current plan from the JCVI announced a month ago is to give an autumn boost to health workers, the over 65's and at-risk groups under 65, I suspect we'll see some kind of U-turn and a wider boost when we get to autumn, especially given some of the concerning news about how different the latest variants are antigenically and the rate at which immunity seems to fade.